Quick Takeaways
- Aberdeen Group plc filed SCHEDULE 13G for Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share (TECX).
- Disclosed ownership: 6.1%.
- Date of event: 31 Dec 2025.
Aberdeen Group plc - 31 Dec 2025 SCHEDULE 13G Report for Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share (TECX)
- Filing Manager
- Aberdeen Group plc
- Reporting Manager
- Aberdeen Group plc
- Symbol
- TECX
- Shares outstanding
- 18,718,426 shares
- Disclosed Ownership
- 1,141,824 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G
- Filing time
- 29 Jan 2026, 15:15:06 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Aberdeen Group plc disclosed 6.1% ownership in Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share (TECX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Jan 2026, 15:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Aberdeen Group plc | 6.1% | 1,141,824 | 0 | 1,141,824 | L.Beaton | Lyn Beaton/ Senior Major Shareholding Reporting Analyst | |
| abrdn Inc | 6.1% | 1,141,824 | 0 | 1,141,824 | L.Beaton | Lyn Beaton/ Senior Major Shareholding Reporting Analyst |